{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T14:36:01Z","timestamp":1771511761199,"version":"3.50.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,2,21]]},"DOI":"10.7759\/cureus.22449","type":"journal-article","created":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T15:29:32Z","timestamp":1645457372000},"source":"Crossref","is-referenced-by-count":7,"title":["Efficacy of Behavioural Intervention, Antipsychotics, and Alpha Agonists in the Treatment of Tics Disorder in Tourette\u2019s Syndrome"],"prefix":"10.7759","author":[{"given":"Muneeba","family":"Rizwan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noor ul ain","family":"Shahid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noreen","family":"Naguit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rakesh","family":"Jakkoju","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sadia","family":"Laeeq","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tiba","family":"Reghefaoui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hafsa","family":"Zahoor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ji Hyun","family":"Yook","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lubna","family":"Mohammed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2018.00139","article-title":"Tourette syndrome: a mini-review","volume":"9","author":"Novotny M","year":"2018","unstructured":"Novotny M, Valis M, Klimova B. Tourette syndrome: a mini-review. Front Neurol. 2018, 9:139. 10.3389\/fneur.2018.00139","journal-title":"Front Neurol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.5863\/1551-6776-25.5.401","article-title":"A review of the current treatment of Tourette syndrome","volume":"25","author":"Seideman MF","year":"2020","unstructured":"Seideman MF, Seideman TA. A review of the current treatment of Tourette syndrome. J Pediatr Pharmacol Ther. 2020, 25:401-12. 10.5863\/1551-6776-25.5.401","journal-title":"J Pediatr Pharmacol Ther"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1212\/CON.0000000000000752","article-title":"Tics and Tourette syndrome","volume":"25","author":"Singer HS","year":"2019","unstructured":"Singer HS. Tics and Tourette syndrome. Continuum (Minneap Minn). 2019, 25:936-58. 10.1212\/CON.0000000000000752","journal-title":"Continuum (Minneap Minn)"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3238\/arztebl.2012.0821","article-title":"Tourette syndrome and other tic disorders in childhood, adolescence and adulthood","volume":"109","author":"Ludolph AG","year":"2012","unstructured":"Ludolph AG, Roessner V, M\u00fcnchau A, M\u00fcller-Vahl K. Tourette syndrome and other tic disorders in childhood, adolescence and adulthood. Dtsch Arztebl Int. 2012, 109:821-288. 10.3238\/arztebl.2012.0821","journal-title":"Dtsch Arztebl Int"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychores.2009.06.006","article-title":"The genetics of Tourette syndrome: a review","volume":"67","author":"O'Rourke JA","year":"2009","unstructured":"O'Rourke JA, Scharf JM, Yu D, Pauls DL. The genetics of Tourette syndrome: a review. J Psychosom Res. 2009, 67:533-45. 10.1016\/j.jpsychores.2009.06.006","journal-title":"J Psychosom Res"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1080\/14656566.2020.1721465","article-title":"Current pharmacotherapy for tic disorders","volume":"21","author":"Cothros N","year":"2020","unstructured":"Cothros N, Medina A, Pringsheim T. Current pharmacotherapy for tic disorders. Expert Opin Pharmacother. 2020, 21:567-80. 10.1080\/14656566.2020.1721465","journal-title":"Expert Opin Pharmacother"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.braindev.2014.11.005","article-title":"Tourette syndrome: update","volume":"37","author":"Hallett M","year":"2015","unstructured":"Hallett M. Tourette syndrome: update. Brain Dev. 2015, 37:651-5. 10.1016\/j.braindev.2014.11.005","journal-title":"Brain Dev"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s13311-020-00914-6","article-title":"Current management of tics and Tourette syndrome: Behavioral, pharmacologic, and surgical treatments","volume":"17","author":"Billnitzer A","year":"2020","unstructured":"Billnitzer A, Jankovic J. Current management of tics and Tourette syndrome: Behavioral, pharmacologic, and surgical treatments. Neurotherapeutics. 2020, 17:1681-93. 10.1007\/s13311-020-00914-6","journal-title":"Neurotherapeutics"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1212\/CPJ.0000000000000348","article-title":"Behavioral therapy for Tourette syndrome and chronic tic disorders","volume":"7","author":"Fr\u00fcndt O","year":"2017","unstructured":"Fr\u00fcndt O, Woods D, Ganos C. Behavioral therapy for Tourette syndrome and chronic tic disorders. Neurol Clin Pract. 2017, 7:148-56. 10.1212\/CPJ.0000000000000348","journal-title":"Neurol Clin Pract"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2017.00032","article-title":"The efficacy and tolerability of the clonidine transdermal patch in the treatment for children with tic disorders: a prospective, open, single-group, self-controlled study","volume":"8","author":"Song PP","year":"2017","unstructured":"Song PP, Jiang L, Li XJ, Hong SQ, Li SZ, Hu Y. The efficacy and tolerability of the clonidine transdermal patch in the treatment for children with tic disorders: a prospective, open, single-group, self-controlled study. Front Neurol. 2017, 8:32. 10.3389\/fneur.2017.00032","journal-title":"Front Neurol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-020-04327-3","article-title":"Pharmacotherapy for tics in adult patients with Tourette syndrome and other tic disorders","volume":"41","author":"Badenoch J","year":"2020","unstructured":"Badenoch J, Cavanna AE. Pharmacotherapy for tics in adult patients with Tourette syndrome and other tic disorders. Neurol Sci. 2020, 41:1923-6. 10.1007\/s10072-020-04327-3","journal-title":"Neurol Sci"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2017.4317","article-title":"Efficacy and safety of deep brain stimulation in Tourette syndrome: the International Tourette Syndrome Deep Brain Stimulation Public Database and Registry","volume":"75","author":"Martinez-Ramirez D","year":"2018","unstructured":"Martinez-Ramirez D, Jimenez-Shahed J, Leckman JF, et al.. Efficacy and safety of deep brain stimulation in Tourette syndrome: the International Tourette Syndrome Deep Brain Stimulation Public Database and Registry. JAMA Neurol. 2018, 75:353-9. 10.1001\/jamaneurol.2017.4317","journal-title":"JAMA Neurol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1089\/cap.2016.0026","article-title":"Randomized, double-blind, placebo-controlled trial demonstrates the efficacy and safety of oral aripiprazole for the treatment of Tourette's disorder in children and adolescents","volume":"27","author":"Sallee F","year":"2017","unstructured":"Sallee F, Kohegyi E, Zhao J, et al.. Randomized, double-blind, placebo-controlled trial demonstrates the efficacy and safety of oral aripiprazole for the treatment of Tourette's disorder in children and adolescents. J Child Adolesc Psychophar. 2017, 27:771-81. 10.1089\/cap.2016.0026","journal-title":"J Child Adolesc Psychophar"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1017\/S1461145705005365","article-title":"Case series on the use of aripiprazole for Tourette syndrome","volume":"8","author":"Murphy TK","year":"2005","unstructured":"Murphy TK, Bengtson MA, Soto O, Edge PJ, Sajid MW, Shapira N, Yang M. Case series on the use of aripiprazole for Tourette syndrome. Int J Neuropsychopha. 2005, 8:489-90. 10.1017\/S1461145705005365","journal-title":"Int J Neuropsychopha"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000055434.39968.67","article-title":"A placebo-controlled trial of risperidone in Tourette syndrome","volume":"60","author":"Scahill L","year":"2003","unstructured":"Scahill L, Leckman JF, Schultz RT, Katsovich L, Peterson BS. A placebo-controlled trial of risperidone in Tourette syndrome. Neurology. 2003, 60:1130-5. 10.1212\/01.wnl.0000055434.39968.67","journal-title":"Neurology"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1007\/s00787-011-0163-7","article-title":"European clinical guidelines for Tourette syndrome and other tic disorders. Part II: pharmacological treatment","volume":"20","author":"Roessner V","year":"2011","unstructured":"Roessner V, Plessen KJ, Rothenberger A, et al.. European clinical guidelines for Tourette syndrome and other tic disorders. Part II: pharmacological treatment. Eur Child Adolesc Psychi. 2011, 20:173-96. 10.1007\/s00787-011-0163-7","journal-title":"Eur Child Adolesc Psychi"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1007\/s40263-017-0486-0","article-title":"Current approaches and new developments in the pharmacological management of Tourette syndrome","volume":"32","author":"Quezada J","year":"2018","unstructured":"Quezada J, Coffman KA. Current approaches and new developments in the pharmacological management of Tourette syndrome. CNS Drugs. 2018, 32:33-45. 10.1007\/s40263-017-0486-0","journal-title":"CNS Drugs"},{"key":"ref18","article-title":"Prescriptions for alpha agonists and antipsychotics in children and youth with tic disorders: a pharmacoepidemiologic study","volume":"15","author":"Cothros N","year":"2019","unstructured":"Cothros N, Martino D, McMorris C, Stewart D, Tehrani A, Pringsheim T. Prescriptions for alpha agonists and antipsychotics in children and youth with tic disorders: a pharmacoepidemiologic study. Trem Oth Hyper Mov. 2019, 15:2021-15.","journal-title":"Trem Oth Hyper Mov"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1080\/00048670802277222","article-title":"Randomized double-blind multicentre placebo-controlled clinical trial of the clonidine adhesive patch for the treatment of tic disorders","volume":"42","author":"Du YS","year":"2008","unstructured":"Du YS, Li HF, Vance A, et al.. Randomized double-blind multicentre placebo-controlled clinical trial of the clonidine adhesive patch for the treatment of tic disorders. Aust N Z J Psychiatry. 2008, 42:807-13. 10.1080\/00048670802277222","journal-title":"Aust N Z J Psychiatry"},{"key":"ref20","article-title":"Mechanism of action of guanfacine: a postsynaptic differential approach to the treatment of attention deficit hyperactivity disorder (adhd)","volume":"44","author":"Alamo C","year":"2016","unstructured":"Alamo C, L\u00f3pez-Mu\u00f1oz F, S\u00e1nchez-Garc\u00eda J. Mechanism of action of guanfacine: a postsynaptic differential approach to the treatment of attention deficit hyperactivity disorder (adhd). Actas Esp Psiquiatr. 2016, 44:107-12.","journal-title":"Actas Esp Psiquiatr"},{"key":"ref21","article-title":"Guanfacine for the treatment of cognitive disorders: a century of discoveries at Yale","volume":"85","author":"Arnsten AF","year":"2012","unstructured":"Arnsten AF, Jin LE. Guanfacine for the treatment of cognitive disorders: a century of discoveries at Yale. Yale J Biol Med. 2012, 85:45-58.","journal-title":"Yale J Biol Med"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.56.5.599","article-title":"Baclofen treatment in Tourette syndrome: a double-blind, placebo-controlled, crossover trial","volume":"56","author":"Singer HS","year":"2001","unstructured":"Singer HS, Wendlandt J, Krieger M, Giuliano J. Baclofen treatment in Tourette syndrome: a double-blind, placebo-controlled, crossover trial. Neurology. 2001, 56:599-604. 10.1212\/wnl.56.5.599","journal-title":"Neurology"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.57.8.1190","article-title":"Botulinum toxin in the treatment of tics","volume":"57","author":"Kwak CH","year":"2000","unstructured":"Kwak CH, Hanna PA, Jankovic J. Botulinum toxin in the treatment of tics. Arch Neurol. 2000, 57:1190-3. 10.1001\/archneur.57.8.1190","journal-title":"Arch Neurol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000002977","article-title":"Child neurology: diagnosis and treatment of Tourette syndrome","volume":"87","author":"Hirschtritt ME","year":"2016","unstructured":"Hirschtritt ME, Dy ME, Yang KG, Scharf JM. Child neurology: diagnosis and treatment of Tourette syndrome. Neurology. 2016, 87:e65-7. 10.1212\/WNL.0000000000002977","journal-title":"Neurology"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.3310\/hta20040","article-title":"Clinical effectiveness and patient perspectives of different treatment strategies for tics in children and adolescents with Tourette syndrome: a systematic review and qualitative analysis","volume":"20","author":"Hollis C","year":"2016","unstructured":"Hollis C, Pennant M, Cuenca J, et al.. Clinical effectiveness and patient perspectives of different treatment strategies for tics in children and adolescents with Tourette syndrome: a systematic review and qualitative analysis. Health Technol Assess. 2016, 20:1-450, vii-viii. 10.3310\/hta20040","journal-title":"Health Technol Assess"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/77865-efficacy-of-behavioural-intervention-antipsychotics-and-alpha-agonists-in-the-treatment-of-tics-disorder-in-tourettes-syndrome","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:45:47Z","timestamp":1707507947000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/77865-efficacy-of-behavioural-intervention-antipsychotics-and-alpha-agonists-in-the-treatment-of-tics-disorder-in-tourettes-syndrome"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,21]]},"references-count":25,"URL":"https:\/\/doi.org\/10.7759\/cureus.22449","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2,21]]}}}